With the analysis among 578 patents, we discovered top 129 key players by total patent application. MyoKardia, Inc., AstraZeneca Pharmaceutical Co., Ltd., Edwards Lifesciences Corp. are dominant in this area. They take 16.61% of the total patent filing.
California, United States
Patent: 35
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 31
Edwards Lifesciences Corp.
California, United States
Patent: 30
Arena Pharmaceuticals, Inc.
California, United States
Patent: 28
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 25
Zensun Sci. & Tech. Co., Ltd.
Shanghai Shi, China
Patent: 18
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 15
Noord-Holland, Netherlands
Patent: 13
Pennsylvania, United States
Patent: 11
With the analysis among 27 patents, we discovered top 10 start-ups by total patent application. Precordior Oy, Institut National de la Santé et de la Recherche Médicale, Ultromics Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Illinois, United States
Patent: 2
Imbria Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 2
Victoria, Australia
Patent: 1
Shanghai Xingmai Information Technology Co. Ltd.
Shanghai Shi, China
Patent: 1
California, United States
Patent: 1
Shanghai Shenzhi Information Technology Co., Ltd.
Shanghai Shi, China
Patent: 1
With the analysis among related 394 patents applied in the last 5 years. We discover 122 most active companies in this area. The fast-growing MyoKardia, Inc., AstraZeneca Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd. take 20.56% of patent filing during this period.
California, United States
Patent: 35
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 31
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 15
Arena Pharmaceuticals, Inc.
California, United States
Patent: 15
Pennsylvania, United States
Patent: 11
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 10
Indiana, United States
Patent: 8
With the analysis among related 394 patents in last 5 years, we discover 101 new entrants. MyoKardia, Inc., AstraZeneca Pharmaceutical Co., Ltd., Shenzhen Salubris Pharmaceuticals Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 35
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 31
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Guangdong Sheng, China
Patent: 15
Pennsylvania, United States
Patent: 11
Indiana, United States
Patent: 8
Case Western Reserve University
Ohio, United States
Patent: 7
Board of Trustees of the Leland Stanford Junior University
California, United States
Patent: 7
ALLEGRO PHARMACEUTICALS, LLC
With the analysis among 175 patents, we discovered top 43 universities and scientific research institutions by total patent application. California Institute of Technology, Case Western Reserve University, University of Miami are dominant in this area. They take 14.29% of the total patent filing.
California Institute of Technology
California, United States
Patent: 8
Case Western Reserve University
Ohio, United States
Patent: 7
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 5
Southern Medical University
Guangdong Sheng, China
Patent: 5
Kharkiv National Medical University
The Johns Hopkins University
University of British Columbia
British Columbia, Canada
Patent: 4
North Carolina, United States
Patent: 3
The George Washington University Medical Center
District of Columbia, United States
Patent: 3